ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $725,000 | -25.4% | 32,300 | 0.0% | 0.02% | -23.1% |
Q4 2017 | $972,000 | -20.1% | 32,300 | 0.0% | 0.03% | -16.1% |
Q3 2017 | $1,216,000 | +35.1% | 32,300 | 0.0% | 0.03% | +29.2% |
Q2 2017 | $900,000 | -18.9% | 32,300 | 0.0% | 0.02% | -22.6% |
Q1 2017 | $1,110,000 | +0.5% | 32,300 | -15.7% | 0.03% | -6.1% |
Q4 2016 | $1,104,000 | -9.4% | 38,300 | 0.0% | 0.03% | +17.9% |
Q3 2016 | $1,218,000 | -2.0% | 38,300 | 0.0% | 0.03% | -9.7% |
Q2 2016 | $1,243,000 | -3.3% | 38,300 | -16.7% | 0.03% | +6.9% |
Q1 2016 | $1,286,000 | – | 46,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |